Aethlon Medical Inc. Common Stock is a biomedical technology company focused on developing innovative therapeutic devices to address unmet medical needs in the fields of cancer, infectious diseases, and neurodegenerative disorders. Its flagship product, the Hemopurifier, is a blood purification system designed to remove harmful viruses and cancer-causing particles from the bloodstream, potentially transforming the way we treat these conditions.
